73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells
Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye
AI can be used to detect and grade prostate cancer

AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw

AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw
Study opens door to targeted treatments for oesophageal cancer

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted
Unique gene signature could help predict response to chemotherapy

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations
Mailed orders found to double liver cancer screening rates

Mailed orders found to double liver cancer screening rates

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainLiver cancer screening among patients with cirrhosis almost doubled when they were mailed a signe

Mailed orders found to double liver cancer screening rates

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainLiver cancer screening among patients with cirrhosis almost doubled when they were mailed a signe
Half the amount of chemo prevents testicular cancer from coming back, new trial shows

Half the amount of chemo prevents testicular cancer from coming back, new trial shows

byInstitute of Cancer ResearchMicrograph of seminoma testes showing lobules of uniform cells separated by delicate septae of fibrous tissue. Credit: Calicut Medical College via Wikimedia. Licens

Half the amount of chemo prevents testicular cancer from coming back, new trial shows

byInstitute of Cancer ResearchMicrograph of seminoma testes showing lobules of uniform cells separated by delicate septae of fibrous tissue. Credit: Calicut Medical College via Wikimedia. Licens
Scientists identify a gene signature to assess cancer risk in people

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron
Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar
New algorithm detects even the smallest cancer metastases across the entire mouse body

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat
Germany's BioNTech plans UK trial of mRNA cancer therapy

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in
HPV blood test shows promise for tracking head and neck cancer after treatment

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he